Substance / Medication

Naratriptan

Overview

Active Ingredient
naratriptan
RxNorm CUI
141366

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The sumatriptan/naratriptan aggregated patient (SNAP) database: aggregation, validation and application.
Barrows C, Saunders W, Austin R et al. · Cephalalgia · 2004
PMID: 15196301Observational
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials.
Ashcroft Darren M, Millson David · Pharmacoepidemiol Drug Saf · 2004
PMID: 14998068Observational
The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat.
Hoskin Karen Lisa, Lambert Geoffrey Andrew, Donaldson Cathy et al. · Brain Res · 2004
PMID: 14725972Observational
Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases.
Rapoport Alan M, Bigal Marcelo E, Volcy Michel et al. · Headache · 2003
PMID: 12752754Observational
Building on the sumatriptan experience: the development of naratriptan.
Connor H E · Cephalalgia · 2001
PMID: 11678820Observational
Naratriptan in the Prophylactic Treatment of Cluster Headache.
Ito Yasuo, Mitsufuji Takashi, Asano Yoshio et al. · Intern Med · 2017
PMID: 28883254Case ReportFull text (PMC)
Isolated naratriptan-associated ischemic colitis.
Akbar Asra, Nissan George, Chaudhry Priyanka et al. · Proc (Bayl Univ Med Cent) · 2016
PMID: 27695179Case ReportFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Naratriptan (substance)
SNOMED CT
363571003
UMLS CUI
C0540623
RxNorm CUI
141366

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.